Wells Fargo & Company ALNYLAM PHARMACEUTICALS INC Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Number of Shares
3,023,000
Previous 2,782,000
8.66%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions